A multifaceted approach to quality in the MRI-directed biopsy pathway for prostate cancer diagnosis

Eur Radiol. 2021 Jun;31(6):4386-4389. doi: 10.1007/s00330-020-07527-9. Epub 2020 Nov 25.

Abstract

• Identify, assure, and measure major sources of variability affecting the MRI-directed biopsy pathway for prostate cancer diagnosis.• Develop strategies to control and minimize variations that impair pathway effectiveness including the performance of main players and team working.• Assure end-to-end quality of the diagnostic chain with robust multidisciplinary team working.

Publication types

  • Editorial

MeSH terms

  • Biopsy
  • Humans
  • Image-Guided Biopsy
  • Magnetic Resonance Imaging
  • Male
  • Prostatic Neoplasms* / diagnostic imaging